Ce. Med Klin (Munich) 2008, 103(9):628?32. Rossini R, Musumeci G, Lettieri C, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/20460822 et al: Outcomes of long-term triple therapy with aspirin, clopidogrel, and warfarin in patientsundergoing coronary stenting [abstract]. Eur Heart 2008, 29(Suppl):328. Valencia J, Mainar V, Bordes P, et al: Observance of Antiplatelet Therapy after Stent Implantation in Patients under Chronic Oral Anticoagulant Treatment. J Interven Cardiol 2008, 21:218?24. Gao F, Zhou YJ, Wang ZJ, et al: Comparison of Different Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation. Circ J 2010, 74:701?08. Sambola A, Ferreira-Gonz ez I, Angel J, et al: Therapeutic strategies after coronary stenting in chronically anticoagulated patients: the MUSICA study. Heart 2009, 95(18):1483?488. Gilard M, Blanchard D, Helft G, et al: Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]). Am J Cardiol 2009, 104(3):338?42. H g C, Brunner-La Rocca HP, Kaiser C, et al: Early and late increased bleeding rates after angioplasty and stenting due to combined antiplatelet and anticoaglant therapy. EuroIntervention 2009, 5:425?31. Halbfass P, Janko S, Dorwarth U, et al: Dilemma of antithrombotic therapy in anticoagulated atrial fibrillation patients squeezed between thrombosis and bleeding events: a single-center experience. Europace 2009, 11:957?60. Helft G, Dambrin G, Zaman A, et al: Percutaneous coronary intervention in anticoagulated patients via radial artery access. Catheter Cardiovasc Interv 2009, 73:44?7. Olson KL, Delate T, Johnson SG, et al: Incidence of hemorrhage among anticoagulated patients receiving antiplatelet therapy after percutaneous coronary PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/10572343 intervention. J Thromb Thrombolysis 2009, 29:316?21. Baber U, Akhter M, Kothari S, et al: Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents. J Invasive Cardiol 2010, 22:80?3. Persson J, Lindbaeck J, Hofman-Bang C, et al: Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with Fmoc-Oic-OH acute coronary syndrome. EuroIntervention 2011, 6:1046?052. Uchida Y, Mori F, Ogawa H, et al: Impact of anticoagulant therapy with dual antiplatelet therapy on prognosis after treatment with drug-eluting coronary stents. J Cardiol 2010, 55:362?69. Guasch E, Sionis A, Reverter JC, et al: Safety issues of adjunctive clopidogrel in patients discharged after percutaneous coronary intervention with stent placement and requiring oral anticoagulation. Int J Cardiol 2011, 146:e1 4. Jang S-W, Rho T-H, Kim D-B, et al: Optimal antithrombotic strategy 3-Chloro-5-cyclopropylpyridine in patients with atrial fibrillation after coronary stent implantation. Korean Circ J 2011, 41:578?82. Zhao H-J, Zheng Z-T, Wang Z-H, et al: "Triple Therapy" Rather Than "Triple Threat" A Meta-analysis of the Two Antithrombotic Regimens After Stent Implantation in Patients Receiving Long-term Oral Anticoagulant Treatment. Chest 2011, 139(2):260?70. Rubboli A, Halperin JL: Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions. Thromb Haemost 2008, 100(5):752?53. Faxon DP, Eikelboom JW, Berger PB, et al: Consensus Document: Antithrombotic therapy in patients with atriale fibrillation undergoing coronary stenting.